The present disclosure relates to infusion therapy with vascular access devices. Infusion therapy is one of the most common health care procedures. Hospitalized, home care, and other patients receive fluids, pharmaceuticals, and blood products via a vascular access device inserted into the vascular system. Infusion therapy may be used to treat an infection, provide anesthesia or analgesia, provide nutritional support, treat cancerous growths, maintain blood pressure and heart rhythm, or many other clinically significant uses.
Infusion therapy is facilitated by a vascular access device. The vascular access device may access a patient's peripheral or central vasculature. The vascular access device may be indwelling for short term (days), moderate term (weeks), or long term (months to years). The vascular access device may be used for continuous infusion therapy or for intermittent therapy.
A common vascular access device is a catheter that is inserted into a patient's vein. The catheter length may vary from a few centimeters for peripheral access to many centimeters for central access. The catheter may be inserted transcutaneously or may be surgically implanted beneath the patient's skin. The catheter, or any other vascular access device attached thereto, may have a single lumen or multiple lumens for infusion of many fluids simultaneously. A group of vascular access and other devices used to access the vasculature of a patient may be collectively referred to as an extravascular system.
One example of an extravascular system including a catheter is the BD NEXIVA™ Closed IV (intravenous) Catheter System, by Becton, Dickinson and Company. This system includes an over-the-needle, peripheral intravascular catheter made from polyurethane, another catheter used as an integrated extension tubing with a Y adapter and slide clamp, a vent plug, a Luer access device or port, and a passive needle-shielding mechanism.
The design of the BD NEXIVA™ IV catheter can be described as a closed system since it protects clinicians or operators from blood exposure during the catheter insertion procedure. Since the needle is withdrawn through a septum that seals, after the needle has been removed and both ports of the Y adapter are closed, blood is contained within the NEXIVA™ device during catheter insertion. The pressure exerted on the needle as it passes through the septum wipes blood from the needle, further reducing potential blood exposure. The slide clamp on the integrated extension tubing is provided to eliminate blood exposure when the vent plug is replaced with another vascular access device such as an infusion set connection or a Luer access device or port.
A current procedure of initiating the use of an extravascular system such as the BD NEXIVA™ Closed IV Catheter System is as follows. A device operator inserts the needle into the vasculature of a patient and waits for flashback of blood to travel into the device to confirm that the needle is properly located within the vasculature of the patient. The blood travels into and along the catheter of the device because a vent plug permits air to escape the device as blood enters the device. After an operator confirms proper placement, the operator clamps the catheter to halt the progression of blood through the catheter, removes the vent plug, replaces the vent plug with another vascular access device such as an infusion set connection or a Luer access port, unclamps the catheter, flushes the blood from the catheter back into the vasculature of the patient, and re-clamps the catheter.
Many current procedures like the procedure described above present challenges that need to be overcome. For example, the procedure may include an unnecessary number of steps and amount of time to simply insert and prepare an extravascular system for use within the vasculature of a patient. Further, by removing the vent plug, the fluid path of the system is temporarily exposed to potential contamination from the external environment of the extravascular system.
Rather than using a vent plug, some operators attempt to solve the problem above by simply loosening a Luer access device and permitting air to escape from the system during flashback and then tightening the Luer access device to stop blood from advancing along the catheter. Unfortunately, this procedure is also prone to user error, a lack of consistent and accurate control of blood flow through the system potentially leading to blood exposure and loss of body fluids, and unnecessary risk of contamination.
Thus, what are needed are improvements to many of the systems and methods described above. Such systems and methods can be improved by providing more efficient vascular access device septum venting systems and methods.
The present invention has been developed in response to problems and needs in the art that have not yet been fully resolved by currently available vascular access systems, devices, and methods. Thus, these systems, devices, and methods are developed to provide more efficient vascular access septum venting systems and methods.
A medical device may include a vascular access device having a septum and a gas permeable vent in communication with at least a portion of the septum. The vent may be capable of venting a gas from an extravascular system to which the device is capable of attaching.
The vent may include an adapter and a vent plug secured to the adapter, a cannula, high-density polyethylene fibers, a vent plug that is closed upon septum actuation, a porous plastic material, a porous fibrous material, a micro tube array, a laminated film vent, and/or a venting plug. The septum may include a top disc and the venting plug may at least in part encapsulate the top disc. The venting plug may also include a narrow cross section.
The septum may include a bi-stable spring which may be embedded within the material of the septum. The vent may also include a cannula and the device may include a chamber in communication with the septum, and the chamber may be filled with gel. The vent may include a needle capable of penetrating the septum.
The vent may also include a hydrophobic thread, a plastic catheter tubing, a round cannula, a flattened cannula, a cross section having a substantially symmetrical cross section with a length greater than the width of the cross, a rigid tubing and a stylet, and/or an activatable venting channel secured to the vascular access device.
A method of venting a medical device may include providing a vascular access device where the vascular access device includes a septum and forms part of an extravascular system, providing a gas permeable vent in communication with at least a portion of the septum, and venting gas from the extravascular system through the gas permeable vent of the vascular access device. The vent may include an adapter and a vent plug secured to the adapter, and the method may include removing the adapter from the vascular access device. The vent may include a vent plug, and the method may include actuating the septum and simultaneously closing the vent plug.
The method may also include inserting a cannula into the septum, inserting a venting material into the septum, piercing the septum with a needle, inserting a micro tube array into the septum, inserting a laminating film vent into the septum, inserting a thread into the septum, inserting a cross into the septum, and/or inserting a stylet into the septum.
The septum may include a top disc and the method may include encapsulating the top disc with a structure in communication with the vent. The septum may include a bi-stable spring, and the method may include actuating the bi-stable spring to close the vent. The method may also include filling a portion of the vascular access device with gel. The step of providing a gas permeable vent in communication with at least a portion of the septum may also include inserting a venting channel into the septum.
A medical device may include a means for providing access to the vascular system of a patient and a means for venting an extravascular system to which the means for providing is capable of attaching. The means for providing access to the vascular system of a patient may include a septum and may form part of the extravascular system. The means for venting the extravascular system may communicate with the septum.
These and other features and advantages of the present invention may be incorporated into certain embodiments of the invention and will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter. The present invention does not require that all the advantageous features and all the advantages described herein be incorporated into every embodiment of the invention.
In order that the manner in which the above-recited and other features and advantages of the invention are obtained will be readily understood, a more particular description of the invention briefly described above will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. These drawings depict only typical embodiments of the invention and are not therefore to be considered to limit the scope of the invention.
The presently preferred embodiments of the present invention will be best understood by reference to the drawings, wherein like reference numbers indicate identical or functionally similar elements. It will be readily understood that the components of the present invention, as generally described and illustrated in the figures herein, could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description, as represented in the figures, is not intended to limit the scope of the invention as claimed, but is merely representative of presently preferred embodiments of the invention.
Referring now to
The system 10 is a closed system since it protects clinicians or operators from blood exposure during the catheter 14 insertion procedure. Since the needle 12 is withdrawn through a septum that seals after the needle 12 has been removed and both ports of the Y adapter 18 are closed, blood is contained within the system 10 during catheter 14 insertion. The pressure exerted on the needle 12 as it passes through the septum wipes blood from the needle 12, further reducing potential blood exposure. The slide clamp 20 on the integrated extension tubing 16 is provided to eliminate blood exposure when the vent plug 22 is replaced with another vascular access device such as an infusion set connection or another Luer access device or port 24.
As mentioned above, a current procedure of initiating the use of the extravascular system 10 is as follows. A device operator will insert the needle 12 into the vasculature of a patient and wait for flashback of blood to travel into the system 10 to confirm that the needle 12 is properly located within the vasculature of the patient. The blood travels into and along the catheters 14 and 16 because a vent plug 22 permits air to escape the system 10 as blood enters the system 10. After an operator confirms proper placement, and after adequate venting of the system 10 has occurred, the operator clamps the catheter 16 to halt the progression of blood through the catheters 14 and 16, removes the vent plug 22, replaces the vent plug 22 with another vascular access device such as an infusion set connection or a Luer access device similar or identical to Luer access device or port 24, unclamps the catheter 16, flushes the blood from the catheters 14 and 16 back into the vasculature of the patient, and re-clamps the catheter 16. Alternate vents and venting procedures are desired and will be discussed with reference to the figures following
Referring now to
Referring now to
Referring now to
Referring now to
Below the vent notch 46, the vented cannula 44 also includes one or more features 50 capable of exercising the septum 30 upon removal of the cannula 44 from the device 28. The purpose of the feature 50 is to ensure that the septum 30 fully recovers after the vented cannula 44 is removed therefrom. Recovery of the septum 30 requires that the two opposing surfaces of the slit 36 of the septum 30 come fully into contact with each other after removal of any device therefrom. Full recovery of the septum 30 will prevent any liquid from escaping from the interior chamber 48 to the external environment. If needed, a second and any number of additional features 50 can be added to the end of the vented cannula 44 to create a second or additional exercising of the septum 30 upon cannula 44 removal.
In addition to the one or more features 50, a biocompatible gel may be added to the surface of the features 50 to assist in sealing any hole which may exist between the two surfaces of the slit 36 in the septum 30 until the septum 30 is able to fully recover and be completely sealed. In order to ensure that the vented cannula 44 only vents gas from the interior chamber 48 to the external environment, a hydrophobic membrane 52 or other similar filter may be placed at the external end of the vented cannula which resides outside the septum 30 while the vent notch 46 resides within the interior chamber 48. The hydrophobic membrane 52 may also include a dust cover 54 capable of encapsulating or otherwise protecting the top disc 56 of the septum 30 during device 28 use. Such a protective cover 54 will help to ensure minimal infection of the sterile device 28 during use.
Referring now to
Referring now to
At its opposite end, the venting material 64 may include additional folds capable of providing a pull tab 68 and a protective covering 70. The pull tab 68 provides a structure which an operator may pull in order to fully remove the venting material 64 from the device 28. The protective covering 70 is intended to act as a shield or barrier of an operator's fingers or other instruments from touching the top surface of the top disc 56 of the septum 30 during device 28 use. By acting as a protective covering, the covering 70 prevents septum 30 contamination on the face or top surface of the septum 30 that would otherwise occur or exist if the venting material 64 were pulled straight out of the slit 36 as illustrated in
Referring now to
Referring now to
Referring now to
Referring now to
The supporting materials 74, 82, 86, and 88 of
Referring now to
The porous strip is secured at its external end to a handle 98. The handle 98 may be a simple handle such as that shown in
Referring now to
The cannula 100 with interference housing includes additional housing body along its cross section in order to add additional support and an additional sealing mechanism at a certain cross section of the device 28. Thus the interference housing of the cannula 100 will provide a continuous, sealed, connection of the body 112 of the device 28, the septum 30, and the interference housing of the cannula 100, such that only the lumen 114 of the cannula 100 provides an open space through which fluid, such as a gas, may escape.
The arms 106 may be used as a snap thread connection capable of being rapidly secured to and detached from the threads 108 of the device 28. The vent may also include a gel seal 116 between the lower surface of the body of the end cap 104 and the upper surface of the top disc 56 of the septum 30. The gel seal 116 provides an additional seal, insulator, and elastic buffer between the vent and the device 28. The gel seal 116 may be formed as a sealing ring 118 around the circumference of the bottom surface of the end cap 104.
Referring now to
Referring now to
Referring now to
Upon full venting of the device 28, an operator may insert the tip of another vascular access device, such as a syringe, into the septum 30, causing the at least one bi-stable spring 128 to snap into concave position, closing the slit 36 and the air channel 130 of the septum 30. After the at least one bi-stable spring 128 has snapped or flipped into concave shape, forcing the septum 30 and top disc 56 in a downward direction 132, no further gas or liquid will be permitted to escape the device 128, and the septum 30 may be used for future access and use consistent with its purpose without reversing the at least one bi-stable spring 128 into convex shape, causing the air channel 130 to reopen.
Referring now to
The prefilled gel 134, upon initial access of the septum 30 of the device 28, is initially pushed into the fluid path 136 of the device 28 and the extravascular system 10. As the gel 134 enters into the fluid path 136, it dissolves into the surrounding intravenous fluid infused into the device 28. Any venting member, such as a cannula or other vent material or member mentioned throughout this disclosure, will extend through the slit 36 of the septum 30, through the body of gel 134, and into the end of the fluid path 136, such that the opening of the venting member is exposed to the fluid path 136.
Referring now to
Referring now to
The body of the device 28 will preferably provide adequate support and lateral pressure against the bottom disc 140. Thus, after the at least one needle 138 is removed from the bottom disc 140, the hole where the at least one needle 138 penetrated through the septum 30 will fully seal and close. The sealed septum 30 will prevent any further gas or liquid from escaping through the septum 30 into the external environment in which the device 28 is placed.
Referring now to
The protective cover 144 of the
Referring now to
The thread 154 may be connected to a pull tab 158 which enables an operator to remove the thread 154 from the slit 36 of the septum 30 after the device 28 is fully vented from gas residing therein. The thread 154 may be connected as a single thread by both ends to the pull tab 158 such that the thread forms a continuous loop 160. Alternatively, the pull tab 158 may be connected to one or more individual threads 162 that do not form a loop 160. Any number of loops 160 or individual threads 162 may be combined to form a single vent for the device 28.
Referring now to
A flattened cannula vent 168 may be inserted within the slit 36 of a septum 30 of a vascular access device 28. The flattened cannula vent may be formed of a flattened metal or other rigid cannula material and may include a similar hydrophobic or venting material within the lumen 170 of the cannula 168. The flattened cross section and rounded narrow corners 172 of the vent 168 will provide minimal stress 174 to the body of the septum 30. Under minimal or reduced stress 174, the septum 30 will be more likely to fully recover and seal after the cannula vent 168 is removed from the slit 36 of the septum 30.
A round cannula vent 176 may also be inserted within the slit 36 of a septum 30 of a vascular access device 28. The round cannula vent 176 will provide high stress 178 to the body of the septum 30 in contrast to the reduced or minimal stress 174 of the flattened cannula vent 168 shown in
A vascular access device 28 may also include a septum 30 with a vent inserted into the slit 36 of the septum 30. A cross section of the vent includes a substantially symmetrical cross 180 formation with a length that is greater than the width of the cross 180. The length of the cross 180 spans to near the full length of the slit 36. The width of the cross 180 provides structure capable of opening the slit 36 to an adequate degree capable of providing four sections of vent volume between each of the four ends of the cross 180 and the slit 36. Each of the ends of the cross 180 are rounded in order to prevent any damage or cutting into the material of the septum 30. The total vent volume between the cross 180 and the surfaces of the slit 36 will be adequate to vent air or other gas from an extravascular system 10 to which the device 28 is attached, and may include any venting material and/or hydrophobic material or surfaces thereon.
Because the cross 180 provides minimal opening of the slit 36 of the septum 30, it will minimize the amount of stress and consequently the memory of the body of the septum 30, permitting the septum to fully recover and become sealed after the cross 180 is removed from the device 28.
The cross 180 will thus provide less stress on the material of the septum 30 than the round cannula 176. The round cannula 176 will provide a higher level of stress 178 and consequently greater septum memory and more likelihood that leaks will occur within the slit 36 of the septum 30. If molded, the cross 180 will preferably be molded, such that the flash locations 182 will be located on any outer surface of the cross 180 that does not come into contact with the surface of the slit 36 of the septum 30. Thus, the remaining material at the flash locations 182 will be unable to damage the surface of the interior surface of the septum 30, causing rips, tears, or other actuations likely to damage or otherwise loosen or dislodge material from the septum 30.
Referring now to
During use, an operator may permit the device 28 to vent while the rigid tubing is inserted into the septum 30. After venting, the operator may pull the puller 194, causing the stylet 192 to pull the structure 190 through the funnel 188 of the rigid tubing 184, causing the rigid tubing 184, venting membrane 186, stylet 192 and structure 190 to be removed from the device 28. After these structures are removed from the device 28, the slit 36 of the septum 30 will return to its original resting, and sealed, position, preventing any additional gas and/or liquid from leaking through the septum 30 into the external environment.
Referring now to
At a second end of the venting channel 196, a vent plug housing 204 that includes the venting channel 196 as its lumen, includes a vent plug or vent membrane 206. The vent plug or vent membrane 206 may include any venting material capable of permeability to gas but not liquid as discussed throughout this disclosure. The housing 198 may further include a vent activation stop 208 on its interior surface capable of stopping the vent channel housing 204 from advancing too far into and through the slit 36 of the septum 30. When the vent activation stop 208 comes into contact with a vent channel stop 210, the housing 204 will no longer advance into the device 28.
Thus, in use, an operator may advance the venting channel 196 into the slit 36 of the septum 30 to provide a means for venting gas from an extravascular system 10 to which the device 28 is attached. After venting is adequately accomplished, the operator may either remove the entire vent housing 198 from the device 28 or may retract the venting channel housing 204 from the septum 30. Once removed or retracted, the vent will leave the slit 36 of the septum 30 in a resting or sealed state capable of preventing any gas or liquid from escaping the device 28. The vent may be activated either by sliding the vent channel housing 204 or by screwing threads of the vent channel housing 204 into corresponding threads of the vent housing 198.
The present invention may be embodied in other specific forms without departing from its structures, methods, or other essential characteristics as broadly described herein and claimed hereinafter. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application claims the benefit of U.S. Provisional Application No. 60/864,510, filed Nov. 6, 2006, entitled VASCULAR ACCESS DEVICE SEPTUM VENTING, which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
60864510 | Nov 2006 | US |